Search
for
Sort by
Research 121–150 of 1000+
- African Journal of Biomedical Research
- Evaluating Carthamus Oxyacantha For 5α-Reductase Inhibition: Therapeutic Perspectives In BPH
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- Dutasteride/finasteride
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Medical consequences of long-term anabolic-androgenic Steroids (AASs) abuses in athletes
- Chapter 6. Darwinian Health and Other Contradictions
- Androstenedione
- STUDIED ON TOXICITY OF HYDROCORTISONE 17-BUTYRATE 21-PROPIONATE : 6. Subacute Toxicity in Dogs by Percutaneous Adminisration
- Prostate Cancer Early Detection, Version 2.2015
- Risks and side effects in the medical management of benign prostatic hyperplasia
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia
- Factors Driving Unique Urination Phenotypes of Male and Female 9-week-old C57BL/6J Mice
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- 9 Role of 5α-reductase in health and disease
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia
- Finasteride-its impact on sexual function and prostate cancer
- Novel inhibitors of 5α-reductase
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis